‘It Was a Good Lesson’: FDA Reconsiders CAR-T Boxed Warning on Secondary Cancers, Peter Marks Says

An FDA announcement last year led to classwide black boxed warnings on existing CAR-T products’ labels. Now FDA is reconsidering those serious safety warnings with plans to change them potentially, Dr. Peter Marks, said in an interview with Fierce Pharma.